Abstract
Gene regulatory networks present a wide variety of dynamical responses to intrinsic and extrinsic perturbations. An outstanding case of such coordinated responses is that of transcriptional amplification cascades, in which activation of a few key-responsive transcription factors (termed master regulators) leads to a large series of transcriptional activation events. Recent studies have pointed to the protein called myocyte enhancing factor 2C (MEF2C) as being one of such master regulators involved in the pathogenesis of primary breast cancer. A systems biology analysis of the transcriptional regulation activity of MEF2C and its target genes, has revealed that this molecule induces collective responses leading to system-level gene expression deregulation and carcinogenesis. We found extensive evidence for this. Being this the case, one may wonder what set of physicochemical, structural and thermodynamic constrains need to be satisfied if a protein is to become a transcription factor, and moreover a master regulator? Some hints will be discussed.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Affara M, Sanders D, Araki H, Tamada Y, Dunmore BJ, Humphreys S, Imoto S, Savoie C, Miyano S, Kuhara S, Jeffries D, Print C, Charnock-Jones DS (2013) Vasohibin-1 is identified as a master-regulator of endothelial cell apoptosis using gene network analysis. BMC Genomics 14:23
Álvarez-Buylla ER, Pelaz S, Liljegren SJ, Gold SE, Burgeff C, Ditta GS, Ribas de Pouplana L, Martínez-Castilla L, Yanofsky MF (2000) An ancestral MADS-box gene duplication occurred before the divergence of plants and animals. Proc Natl Acad Sci USA 97(10):5328–5333
Arnold P, Erb I, Pachkov M, MOlina N, van Nimwegen E (2012) MotEvo: integrated Bayesian probabilistic methods for inferring regulatory sites and motifs on multiple alignments of DNA sequences. Bioinformatics 28(4):487–494
Baca-López K, Hidalgo-Miranda A, Mayorga M, Gutiérrez-Nájera N, Hernández-Lemus E (2012) The role of master regulators in the metabolic/transcriptional coupling in breast carcinomas. PLoS ONE. doi:10.1371/journal.pone.0042678
Basso K, Margolin AA, Stolovitzky G, Klein U, Dalla-Favera R, Califano A (2005) Reverse engineering of regulatory networks in human B cells. Nat Genet 37(4):382–390
Brosh R, Rotter V (2010) Transcriptional control of the proliferation cluster by the tumor suppressor p53. Mol Biosyst 6(1):17–29
Fukuda K (2002) Molecular characterization of regenerated cardiomyocytes derived from adult mesenchymal stem cells. Congenit Anom 42(1):1–9
Hernández-Lemus E (2009) Non-equilibrium thermodynamics of gene expression and transcriptional regulation. J Non-Equilib Thermodyn 34(4):371–394
Hernández-Lemus E, Velázquez-Fernández D, Estrada-Gil JK, Silva-Zolezzi I, Herrera-Hernández MF, Jiménez-Sánchez G (2009) Information theoretical methods to deconvolute genetic regulatory networks applied to thyroid neoplasms. Phys A 388:5057–5069
Hinnebusch AG, Natarajan K (2002) Gcn4p, a master regulator of gene expression, is controlled at multiple levels by diverse signals of starvation and stress. Eukaryot Cell 1:22–32
Homminga I, Pieters R, Langerak AW, de Rooi JJ, Stubbs A, Verstegen M, Vuerhard M, Buijs-Gladdines, J, Kooi C, Klous P, van Vlierberghe P, Ferrando AA, Cayuela JM, Verhaaf B, Beverloo HB, Horstmann M, de Haas V, Wiekmeijer AS, Pike-Overzet K, Staal FJ, de Laat W, Soulier J, Sigaux F, Meijerink JP (2011) Integrated transcript and genome analyses reveal NKX2-1 and MEF2C as potential oncogenes in T cell acute lymphoblastic leukemia. Cancer Cell 19(4):484–497
Hosking R (2012) mTOR: the master regulator. Cell 149:955–957
Janulis, M, Trakul N, Greene G, Schaefer EM, Lee JD, Rosner MR (2001) A novel mitogen-activated protein kinase is responsive to Raf and mediates growth factor specificity. Mol Cell Biol 21(6):2235–2247
Kato Y, Kravchenko VV, Tapping RI, Han J, Ulevitch RJ, Lee JD (1997) BMK1/ERK5 regulates serum-induced early gene expression through transcription factor MEF2C. EMBO J 16(23):7054–7066
Kato Y, Zhao M, Morikawa A, Sugiyama T, Chakravortty D, Koide N, Yoshida T, Tapping RI, Yang Y, Yokochi T, Lee JD (2000) Big mitogen-activated kinase regulates multiple members of the MEF2 protein family. J Biol Chem 275(24):18534–18540
Linnell J, Mott R, Field S, Kwiatkowski DP, Ragoussis J, Udalova IA (2004) Quantitative high-throughput analysis of transcription factor binding specificities. Nucleic Acids Res 32:4
Margolin AA, Nemenman I, Basso K, Wiggins C, Stolovitzky G, Dalla FR, Califano A (2006) ARACNe: an algorithm for the reconstruction of gene regulatory networks in a mammalian cellular context. BMC Bioinf 7(Suppl I S7):1–15
Medvedovic J, Ebert A, Tagoh H, Busslinger M (2011) Pax5: a master regulator of B cell development and leukemogenesis. Adv Immunol 111:179–206
Molkentin JD, Olson EN (1996) Combinatorial control of muscle development by basic helix-loop-helix and MADS-box transcription factors. Proc Natl Acad Sci USA 93(18):9366–9373
Nagel S, Meyer C, Quentmeier H, Kaufmann M, Drexler HG, MacLeod RA (2008) MEF2C is activated by multiple mechanisms in a subset of T-acute lymphoblastic leukemia cell lines. Leukemia 22(3):600–607
Novitch BG, Spicer DB, Kim PS, Cheung WL, Lassar AB (1999) pRb is required for MEF2-dependent gene expression as well as cell-cycle arrest during skeletal muscle differentiation. Curr Biol 9(9):449–459
Nowakowska BA, Obersztyn E, Szyman’ska K, Bekiesin’ska-Figatowska M, Xia Z, Ricks CB, Bocian E, Stockton DW, Szczauba K, Nawara M, Patel A, Scott DA, Cheung SW, Bohan TP, Stankiewicz P (2010) Severe mental retardation, seizures, and hypotonia due to deletions of MEF2C. Am J Med Genet B Neuropsychiatr Genet 153B(5):1042–1051
Poizat C, Sartorelli V, Chung G, Kloner RA, Kedes L (2000) Proteasome-mediated degradation of the coactivator p300 impairs cardiac transcription. Mol Cell Biol 20(23):8643–8654
Potthoff MJ, Olson EN (2007) MEF2: a central regulator of diverse developmental programs. Development 134(23):4131–4140
Sartorelli V, Huang J, Hamamori Y, Kedes L (1997) Molecular mechanisms of myogenic coactivation by p300: direct interaction with the activation domain of MyoD and with the MADS box of MEF2C. Mol Cell Biol 17(2):1010–1026
Smeding L, Leong-Poi H, Hu P, Shan Y, Haitsma JJ, Horvath E, Furmli S, Masoom H, Kuiper JW, Slutsky AS, Parker TG, Plotz FB, dos Santos CC (2012) Salutary effect of resveratrol on sepsis-induced myocardial depression. Crit Care Med 40(6):1896–1907
Stormo GD (2000) DNA binding sites: representation and discovery. Bioinformatics 16:16–23
Subramanian A, Tamayo P, Mootha KV, Mukherjee S, Ebert BL, Gillette MA, Paulovichg A, Pomeroyh SL, Golub TR, Landera ES, Mesirov JP (2005) Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA 102(43):15545–15550
Sun W, Wei X, Kesavan K, Garrington TP, Fan R, Mei J, Anderson SM, Gelfand EW, Johnson GL (2003) MEK kinase 2 and the adaptor protein Lad regulate extracellular signal-regulated kinase 5 activation by epidermal growth factor via Src. Mol Cell Biol 23(7):2298–2308
Wang AH, Bertos NR, Vezmar M, Pelletier N, Crosato M, Heng HH, Th’ng J, Han J, Yang XJ (1999) HDAC4, a Human histone deacetylase related to yeast HDA1, is a transcriptional corepressor. Mol Cell Biol 19(11):7816–7827
Wang AH, Yang XJ (2001) Histone deacetylase 4 possesses intrinsic nuclear import and export signals. Mol Cell Biol 21(17):5992–6005
Whitfield TW, Wang J, Collins PJ, Partridge EC, Aldred SF, Trinklein ND, Myers RM, Weng Z (2012) Functional analysis of transcription factor binding sites in human promoters. Genome Biol 13:R50
Xu J, Cao S, Wang L, Xu R, Chen G, Xu Q (2011) VEGF promotes the transcription of the human PRL-3 gene in HUVEC through transcription factor MEF2C. PLoS ONE 6:11
Yang CC, Ornatsky OI, McDermott JC, Cruz TF, Prody CA (1998) Interaction of myocyte enhancer factor 2 (MEF2) with a mitogen-activated protein kinase, ERK5/BMK1. Nucleic Acids Res 26(20):4771–4777
Acknowledgements
This work was supported by CONACyT (Grant 179431/2012) as well as federal funding from the National Institute of Genomic Medicine (Mexico). Additional support from the National Laboratory of Complexity Sciences is also acknowledged.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer International Publishing Switzerland
About this paper
Cite this paper
Hernández-Lemus, E., Baca-López, K., Tovar, H. (2015). What Makes a Transcriptional Master Regulator? A Systems Biology Approach. In: Olivares-Quiroz, L., Guzmán-López, O., Jardón-Valadez, H. (eds) Physical Biology of Proteins and Peptides. Springer, Cham. https://doi.org/10.1007/978-3-319-21687-4_10
Download citation
DOI: https://doi.org/10.1007/978-3-319-21687-4_10
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-21686-7
Online ISBN: 978-3-319-21687-4
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)